Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) announced that over 35 physicians have written 50+ prescriptions for Imcivree (setmelanotide) for Bardet-Biedl syndrome…
Rhythm Pharmaceuticals (NASDAQ:RYTM) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement.
Analysts estimate that Rhythm Pharmaceuticals will report an earnings per share (EPS) of $-0.95.
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Gainers
Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year growth in revenue for the first quarter.